David Malcom Rodman
CIK 1672659 · Chief Medical Officer · last filed 2026-07-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.42M
Companies
2
Total Filings
105
Lifetime Open-Market Net
-$20.01M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MLYS | Chief Medical Officer | 51,800 | $27.38 | $1.42M | -$19.92M | 56 | 2026-07-20 |
| ALPINE IMMUNE SCIENCES, INC. (NVLS) Delisted | Exec Vice President and CMO | 2,842 | — | — | -$89.2K | 4 | 2017-01-05 |
Recent Filings · Page 2 of 11
105 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-15 | MLYS | Notice (144) | −9,890 | -$235.5K | EDGAR |
| 2026-06-12 | MLYS | Notice (144) | −6,349 | -$151.9K | EDGAR |
| 2026-06-12 | MLYS | Mixed | — | -$164.6K | EDGAR |
| 2026-06-10 | MLYS | Notice (144) | −2,170 | -$54.2K | EDGAR |
| 2026-05-19 | MLYS | Mixed | — | -$5.0K | EDGAR |
| 2026-05-18 | MLYS | Notice (144) | −417 | -$11.5K | EDGAR |
| 2026-05-13 | MLYS | Notice (144) | −14,056 | -$401.8K | EDGAR |
| 2026-05-13 | MLYS | Mixed | −6,349 | -$515.6K | EDGAR |
| 2026-05-12 | MLYS | Notice (144) | −6,348 | -$186.3K | EDGAR |
| 2026-05-11 | MLYS | Notice (144) | −2,171 | -$64.5K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.